<?xml version="1.0" encoding="UTF-8"?>
<ref id="B202">
 <label>202.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>Clinicaltrials.gov</collab>
  </person-group>
  <source>The Impact of Camostat Mesilate on COVID-19 Infection (CamoCO-19)</source>. NCT04321096: Clinicaltrials.gov; (
  <year>2020</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04321096?term=Camostat+mesylate&amp;draw=2&amp;rank=1" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04321096?term=Camostat+mesylate&amp;draw=2&amp;rank=1</ext-link> (accessed April 16, 2020).
 </mixed-citation>
</ref>
